In fact, blocking compensatory leptin response to insulin resistance by inhibiting its synthesis or its effector actions has been implied to be a potential mean to improve metabolic phenotype imposed by insulin resistance (Zhao et al. 2019). The gene discussed is LEP; the disease is Insulin resistance.